1910 Genetics

Private

Boston, MassachusettsHealthcare & Life Scienceshttps://www.1910.ai/

Last Round

Series A

Extension

Oct 31, 2024

Total Funding Raised

$44.65M

Company Overview

1910 Genetics is a biotechnology company that provides a drug discovery platform utilizing multimodal AI and laboratory automation to enhance productivity and reduce failure rates in small and large molecule drug development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Government Contracts

AI Layer

Infrastructure

Keywords

drug discoveryAI drug discoverybiotech AIin silico drug discoverycomputational biologysmall molecule designprotein therapeuticshigh-performance computingHPCblood-brain barrier predictionwet-lab automationdrug discovery platformplatform-as-a-servicePaaSpharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

1910 Genetics Comps

Public and private peers based on sector, stage, and business model.

1910 Genetics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

1910 Genetics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Oct 31, 2024
Grant	Sep 30, 2021
Series A	Mar 23, 2021

View all Funding Rounds

1910 Genetics Investors

Notable investors and investment history

1910 Genetics investors
Investor	Rounds
Scientia Ventures	Seed, Series A
Emles	Seed, Series A
NIH RADx	Grant
FoundersX Ventures	Seed
Playground Global	Series A
M12 - Microsoft's Venture Fund	Series A
Accenture Ventures	Series A Extension

View all Investors

1910 Genetics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

1910 Genetics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 1910 Genetics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts

Employee Range46

Year Founded2018

Last FundingOct 31, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.